| Metric | Q3 2022 | Q2 2022 | Q3 2021 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $320M | $337M | $259M | -5.0% | 23.3% |
| Op. Income | $36M | $50M | $30M | -28.2% | 20.4% |
| Gross Margin | 68.0% | 75.4% | 78.8% | -7.4pp | -10.7pp |
| Net Margin | 13.5% | 54.1% | 10.5% | -40.6pp | 3.0pp |
| EPS (Diluted) | $0.41 | $1.73 | $0.26 | -76.3% | 57.7% |
| Free Cash Flow | $93M | $175M | $76M | -47.0% | 22.0% |
| Item | Amount |
|---|---|
| REVENUE | $320M |
| Cost of Revenue | $102M |
| GROSS PROFIT | $218M |
| R&D Expenses | $0 |
| Selling & Marketing | $46M |
| General & Administrative | $85M |
| SG&A Expenses | $131M |
| Other Expenses | $51M |
| Operating Expenses | $182M |
| Cost & Expenses | $284M |
| OPERATING INCOME | $36M |
| Interest Income | $143M |
| Interest Expense | $20M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $36M |
| Income Tax Expense | -$7M |
| Net Income from Continuing Ops | $43M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $43M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $43M |
| D&A | $11M |
| EBIT | $36M |
| EBITDA | $47M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $320M |
| Cost of Revenue | $102M |
| GROSS PROFIT | $218M |
| R&D Expenses | $0 |
| Selling & Marketing | $46M |
| General & Administrative | $85M |
| SG&A Expenses | $131M |
| Other Expenses | $51M |
| Operating Expenses | $182M |
| Cost & Expenses | $284M |
| OPERATING INCOME | $36M |
| Interest Income | $143M |
| Interest Expense | $20M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $36M |
| Income Tax Expense | -$7M |
| Net Income from Continuing Ops | $43M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $43M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $43M |
| D&A | $11M |
| EBIT | $36M |
| EBITDA | $47M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $43M |
| Depreciation & Amortization | $11M |
| Stock-Based Compensation | $17M |
| Deferred Income Tax | -$5M |
| Other Non-Cash Items | $28M |
| Change in Working Capital | $17M |
| OPERATING CASH FLOW | $110M |
| Capital Expenditure | -$17M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $20M |
| Other Investing Activities | -$716M |
| NET CASH FROM INVESTING | -$713M |
| Net Debt Issuance | -$1.5B |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | $2.0B |
| NET CASH FROM FINANCING | $520M |
| FREE CASH FLOW | $93M |
| Net Change in Cash | -$83M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $953M |
| Short-Term Investments | $359M |
| Net Receivables | $167M |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $1.5B |
| PP&E (Net) | $200M |
| Goodwill | $76M |
| Intangible Assets | $18M |
| Long-Term Investments | $4.6B |
| Tax Assets | $171M |
| Other Non-Current Assets | $263M |
| TOTAL NON-CURRENT ASSETS | $5.3B |
| TOTAL ASSETS | $6.8B |
| Account Payables | $93M |
| Short-Term Debt | $5M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $5.1B |
| TOTAL CURRENT LIABILITIES | $5.2B |
| Long-Term Debt | $114M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $235M |
| TOTAL NON-CURRENT LIABILITIES | $433M |
| TOTAL LIABILITIES | $5.7B |
| Common Stock | $1M |
| Additional Paid-In Capital | $1.6B |
| Retained Earnings | -$451M |
| Treasury Stock | -$98.0K |
| Accum. Other Comp. Income | -$40M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $1.1B |
| Minority Interest | $0 |
| TOTAL EQUITY | $1.1B |
| TOTAL LIABILITIES & EQUITY | $6.8B |
| Total Debt | $202M |
| Net Debt | -$751M |
